current user: public

If you have questions about the server, please let us know.

Query: [E] COG2902 NAD-specific glutamate dehydrogenase, from VFDB

Results of FFAS03 search in PfamA32U
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .  630    .  640    .  650    .  660    .  670    .  680    .  690    .  700    .  710    .  720    .  730    .  740    .  750    .  760    .  770    .  780    .  790    .  800    .  810    .  820    .  830    .  840    .  850    .  860    .  870    .  880    .  890    .  900    .  910    .  920    .  930    .  940    .  950    .  960    .  970    .  980    .  990    . 1000    . 1010    . 1020    . 1030    . 1040    . 1050    . 1060    . 1070    . 1080    . 1090    . 1100    . 1110    . 1120    . 1130    . 1140    . 1150    . 1160    . 1170    . 1180    . 1190    . 1200    . 1210    . 1220    . 1230    . 1240    . 1250    . 1260    . 1270    . 1280    . 1290    . 1300    . 1310    . 1320    . 1330    . 1340    . 1350    . 1360    . 1370    . 1380    . 1390    . 1400    . 1410    . 1420    . 1430    . 1440    . 1450    . 1460    . 1470    . 1480    . 1490    . 1500    . 1510    . 1520    . 1530    . 1540    . 1550    . 1560    . 1570    . 1580    .
# Score Template Links and tools%idFirst MGYRNNPKREKQIEKARQQAIAENVQFLDPGILYGRASADDIEYYSAEMLAASAAHSFEALSHWTGDAPHISITTVEGVSPRDIPVTVLTIIGRNMPFLYDSVMGEVTSSYRGLYLAVHPILVRDDEAQGYRLAEPEDDPAENISLIQLHIAPLTPQAASALEERLRFVLTQVQSAYRDWRPMLTKLDEALDELSKRGSSRRKTERTEAVEFLNWLRNDNFTFLGMRDYTYSGKGKNAKIERGDGVGLGSLSDPDVRVLRLGKNAVTTTPEILAFLDGPDFLIVTKANVKSIVHRRAYMDYIGIKRFDEDGNVIGELRIVGLFTATAYTRSVKQIPLLRAKVADVERHFGFDPNSHSGRILQNTLEAYPRDDLFQIETDLLIRFIEQIMELSDRPRVRVLARIDRFDRFVSAIIFVPREEYNSYVREKIGDYLSRVYDGHISAYYPAFPEGAVARVHFIVGRTEGKTPRIAQDKLEDAVSDIAARWIDHFVALSEPGAPVLDVDQAYQEAFTPEEAIGDMPDILAAANGEPVRIEFYQQEGQSDDTLSLKIFHRDGHLPLSRRVPLLENLGFNVISERTFDIGVVSEGEKRDIVLHDMELSVAAGTTLDLPHYGPKLEEAFLAAFSGKVDNDNFNRLILACGLNVREVSVLRAYARYLRQTGIVYSQEHISETLYKYPDISRNIFALFKAGFDPSIEEKKRVKKLAEIHKAIEAALSGVPNLDEDRTLRRYVNAIDATLRTNYFQKNADGTPRDLLAFKFDPKHLDGLPDPRPFREIFVYGTEVEGVHLRFGKVARGGLRWSDRGQDYRTEVLGLVKAQQVKNAVIVPVGAKGGFFPKNLPAGGSRDEVFNAGREAYKTYIRTLLSITDNIVDDAIVPPADTLRLDGDDPYFVVAADKGTATFSDTANGLAHEAGFWLDDAFASGGSAGYDHKKMGITARGAWETVKRHFREMDTDIQTTPFTVAGVGDMSGDVFGNGMLLSEKIRLIAAFDHRDIFIDPDPDTDKSFAERKRLFELPRSSWQDYDRSTLSAGAMIISRSEKSVTLTPEAVAAIGLDKSVATPFEIMTAILKAPTDLLWFGGIGTYIKAAVETNAEVGDRANDPIRVNATELRAKVIGEGANLGITQKGRIAYALAGGRCNSDAIDNSAGVNSSDVEVNIKIALASAVNSGRLTMPKRNQLLASMTPDVAQLVLRNNYQQSLAISLTERLGLANREELGRLMGALEATGQLNRKVETLPNNAEFSERYASGKPLTRPEIGVLLSYAKLTLFDALVASPLPDEPYLQHLLLDYFPAKMQKNYANDIKAHRLHREIVATALANAVVNRGGPGFVQKLADASGLLAADVVKAAVIVEDGFGLKRLWTEVDALDGKVGGQVQNGLYATITRIFSDASRLYLQTGSAGAAAGDMATEIERLKTAIKTLSPAATKYRRELGVTEIDGVPSGLLEELDTLSLLVYVPEIMRIAESAGTTLARAAESYATVSSTFRVARLLDASQRITPADHYESLALLRSQDQISSSRRRIVISALTEYAKEKDPVQAWYAADRVRVNRIVSELGALSESGDTNLARLTVAAGLLGDIVQARLast
1 -297.000PF05088.12; A4XWG7_PSEMY/77-1608; Bacterial NAD-glutamate dehydrogenase  ali follow..  40  1......................................................................VRAFNPDEKHGWQSTHTAVEILHGDIPFLVDSVRMELNRRGYSIHTLQNSVFSVRRDANGELLEITQGEGVLQEALMFLEIDRCSSAELKTLEKAIHEVFGDVRMSVADFQPMKAKARELLAWLDRAKLKVDKAELEEIKVYLNWLLDNHFTFLGYEEFTVAPSADGGTMVYDEKSLLGLSKRLRTGLTA---EELHIEPEAVAYLREPQLLSFAKAAVPSRVHRPAYPDFVSIRELDAKGNVVKECRFMGLYTSAVYAESVWNIPYIRRKVDVIKQRSGFDSSAHLGKELAQVLEVLPRDDLFQTPVDDLFNTALAIVQIQERNKIRVFLRRDPYGRFCYCLAYVPRDVYSTETRLKIQQVLMDRLQATDCEFWTFFSESVLARVQFILRVDPKNKTQIDPVRLEKEVIQACRSWKDDYASLNVLAEFPGGFPAGYRERFAPHSAVVDMQHLLSLSNDKPLVMSFYQPLAQGDQQLHCKLYHADTPLPLSDVLPILENLGLRVLGEFPYKLRRN---DGREFWIHDFAFTYAEGLDVDIQQLNDTLQDAFIHIVGGDAENDAFNRLVLIAAMPWRDVALLRAYARYLKQIRLGFDLSYIASTLINHADIAKELVRLFRTRFYLARTAEDLEDKQQKLEQAILAALDNVAVLNEDRILRRYLDLIKATLRTNFFQADASGAAKSYFSFKLSPRLIPEIPRPVPKFEIFVYSPRVEGVHLRFGDVARGGLRWSDREEDFRTEVLGLVKAQQVKNAVIVPMGAKGGFVPRKMPVGGSRDEVMAEGIACYRIFISGLLDITDNLKEGEVVPPVNVVRHDADDPYLVVAADKGTATFSDIANGIAAEYGFWLGDAFASGGSAGYDHKGMGITAKGGWVSVQRHFRERGIDVQKDNVTVIGIGDMAGDVFGNGMLLSDKLQLVAAFNHMHIFIDPNPDAAKSFAERKRLFDLPRSSWADYDSKLISEGGGIFLRSAKSITITPQMKARFDIAADKLAPTELLNALLKAPVDLLWNGGIGTYVKSSKESHADVGDKANDALRVDGRELRAKVVGEGGNLGMTQLGRVEFGLHGGASNTDFIDNAGGVDCSDHEVNIKILLGEIVSGGDMTEKQRNKLLAEMTDDVSELVLGNNYKQTQALSLAERRARERVGEYKRLMNALESAGKLDRALEFLPSDEELNERATNGQGLTRPELSVLISYSKIDLKESLLKSLVPDDDYLAREMETAFPEILTEKFGDAMRRHRLKREIVSTQIANDLVNHMGITFVQRLKESTGMSAANVAGAYVIVRDLFRLPHWWAQIEALDYKVPAELQLQLMDELMRLGRRATRWFLRSRRNELDAARDVAHFAPRIEALVGRLDEREQWLARYQSFVEAGTPEELARVVAGTSHLYTLLPIIEAADVTGKDASEVATAYFAVGGALELSWYLQQITNLPVETNWQALAREAFRDDLDWQQRAITVSVLQMPQEIEARVALWLEQHHRLVERWKAMLTELRSATGTDYAMYAVANRELMD..... 1532
2 -19.000PF00208.21; DHE3_ORYSJ/176-408; Glutamate/Leucine/Phenylalanine/Valine dehydrogenase  ali follow..  19  1............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................GGSLG----RDAATGRGVMYATEALLTEYSESISGSTFVIQGLGNVGSWAA--KLIHQKGGKIVAVGDVTGAIRNKSGIDIPALLKHRS----EGGSLEDFYGAEVMDAAELLVHE------------------------------------------CDVLVPCALG---------GVLNRENAAEVKARFIIEGANHPTDTEADEILAKKGVIVLPDIYANSGGVVVSYFE------WVQNIQGFMWDEEKVNRELQKYMKNAFQNIKDMCKSQNCNL-----RMGAFTLGVNRVAKATLLRG.................................................................................................................................................................................................................................................................................................................................................................... 233
3 -13.000PF02812.18; R6WCN3_9CLOT/34-162; Glu/Leu/Phe/Val dehydrogenase, dimerisation domain  ali follow..  27  21...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................FEGFRIQHSTLAKGGVRYHQNVN--VDEVRALSAWMTFKCAVIPYGGGKGGIVCRP------REMSKGELERLTRTYIDKISAIISPNTD-------------------IPAPDVGTNA........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 117
4 -8.120PF02514.16; Q2JMZ0_SYNJB/187-1302; CobN/Magnesium Chelatase  ali follow..  10  97..................................................................................................HYVAMVQELESRGARVVPVFAGGLD-FSKPVNEFFWNAQKTAPIVDVVVSLTGFALVGGPARQDHPKAVEALQRLNRPYMVALPLVFQSTE------------------------EWAASDLGLHPVQVALQIAIPELDGAIDPII---LSGRDAATGKAHAMQDRIELIAARAIKWAN-----LRRKPKLEKKI-------AITVFSFPPDKGNVGTAAYLDVFASIH-------------RVMQALAHNGYDLGPELPKTPQELMESILHDPQAQYASPELNVAAKLSVREYEALTPYVKAIEQYWGPAPGHLNTDGQNLLIYGKHFGNVFIGVQPTFGYEGDPMRLLFSRSASPHHGFAAYYTYLEKVWGADAVLHFGTHGSLEFMPGKQIGMSGECY-------------PDNLIGSLPNLYYYAANNP------EATIAKRRGYACTISYLTPPAENAGLYKGLQEL--EMIGSYQTLREGARGIAIVNAICDNLDKDVDLPAGDAAQLSLEERDTVVGKIKLMEIESRLLPCGLHVIGAPPTAEEAIATLVSIASIDRPEEGILGLPRILAQS-DIDEIYRNRDRGHLADTELLDRINKACQKAVAALVQEQTDAQGRVSRVAKLNFFNMGRQAPWLAVLKEAGYPQVDPDLLKPLFEFLEECLKQITADYELGSLLRALEGEYILPGP---GG--------------------DPIRNPNVLPTGRN------------------------IHALDPQSIPTAAAIKSAEIVVERLLAREMSSNG----GKYPETISVVLWGTDNIKTYGESLAQVLC-----------LGVDALGRVNKVE--LEELGIDV------VVNCSGVFRDLFVNQMLIDRAVKLAAAAVEKHALQQAEELGLTLEQAATRVFSVENSSWEELREMYLSRKSFAFGSNLPNQQMRQLFEASLTVDVTFQNLDSSEISLTDVSHYFDADPTKLVQSLDGKAPSAYMADTTTPNAQIRRLDARTKLL----N-----EGMLKHGYEGVREIAKRLVNTSGWSATAGAVD-----------------------NWIYEETNETFIKDEAMRQ---RLMNLNPHSFRRIVGSLLEVHG-RGYWQTSQANI........................................................................................................................................................................................................................................................................................................................................................... 1116
5 -7.000PF17072.5; SPIKE_BRV1/1-1583; Torovirinae spike glycoprotein  ali follow..  10  170................................................................................................PYMANGVRTRVQSPGIQYEIYSYAVYQITPYTQYTVTMPSGTSGYCQQTPLYVECGSWTPYRVHAYGCDKATQSCNYTISSDWVVAFKSKASAIISQLIVALAQKLSRTVGVNKAVYFWFLKQPYHYLSLVNF---------------SPNYALFSPLCKSLRQQSATYSALSYGSPFFVAQESILFSWDYQVNYPVNNQANETFLQLPTTGYLGQTVSQGRMLNLFKDAIFAVVVKQVPVIAYSAFRIEQQTGYLAVKCNG-----------------VIQATLAPHSSRVVLLARHMSMWSIAAAN------STTIYCPIYTLTSFVRLDISTS-----------FHTLAQPSGPIQQVSMPVLSTGAAGVYMHPMIEHWVTLLAQS-------------------SVYQPSMFNMGVNKSVTLTTQLQAYAQVYTAWFLSI------LYTRLPESRRLTLGAQLTPFIQAL-----------------------------LSFKQADIDATDVDTVARYNVLILMWGRKYAAVIYNQL------EWSYPLFKGGVGDSMWFRKKFLVTTKIHQTASHFPFIAGYL-DFLDYKYIPKYKD---------VACPLSTMVPSILQVYETPQL--FVIIVQCVSTTYSWYPGLRNPHTIYRSYKLGTICV--VPYSSPTDVYSSFGFFFQSA--TTDDILPGCVGFVQDSVFTPCHPSGCPVRNSYDNYIICPGSSASNYTLRNYYRTTTPVTNVPIEEVPLQLEIP-----TVSLTSYELKQSESVLLQDIEGGIVV---DHNTGSI-----------GQAYDVSFYVSVIIRYAPPKLELPSTLANFTSCLDYICFGNQQCRGEAQTFCT---SMDYFEQVFNKSLTSLITALQDLHYVLKLVLPETTLELTEDTRRRRRAVDEFSD-TISLLSESGISLPQRTGSILSSAPSLSSISSWHSYSSRTPLISNVKTPKTTFNVKLSMPKLPKAST---STIGSVLSSGLSIASLGLSIFSIIEDRRV-------IELTQQQIMALEDQITILAGYTTKNFEEIQSSLVQDFSQTSALSLQQLSNGFEQITQQLDKSIYYVMAVQQYATYMSSQAVYKTQDMYITCIHSLQSGVLSPNCITPFQICHLYQVAKNLSSGECQPILSISRFYSLPLVTDAMVHNDTY--SNILGSVYKVQPGYIVNPHHPTSLQYDVPTHVVTSNAGALIFDEHYCDRYNQV--------------YLCTKSAFDL---------------AEASYLTMLYSNQTDNSSLTFHPAPRPDPCVYLSASALYCYYSDECHQCVIAVGNCTNRTVTYENYTYP--MDPQCRGFDQITISSPIAIGADFTALPSRPPLPLHLSVNVTFNV--------TLPNELNWTDLVLDSFKDKVYEISKNITQ------HEQILQVSNWASGWFQRLRDFLGLIPAWITWLTLGFSLFSILISGVNIIL... 1572
6 -6.580PF13740.6; D3RP38_ALLVD/3-79; ACT domain  ali follow..  1....................................................................................EIVLINVTGEDRPGITAALTAILARYQVPILDIGQSTIH-------------------NALALGLLVELPRSGTDCGVFKELLFSAHTLGLDIR............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 75
7 -6.510PF01551.22; Q7MBF2_CHRVO/304-401; Peptidase family M23  ali follow..  20  8.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................YAASAGTPIVA--------------GELVKVARENGYG-NVVMIRHNGKLTTLYAHMSAFGKGIQP---GKVKAGDVIGYVGSTGRSTGAHLHFEVRVNDQPV--DP......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 98
8 -6.250PF10266.9; H2R9P1_PANTR/23-1103; Hereditary spastic paraplegia protein strumpellin  ali follow..  11  1.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................NAIIAELLRLSEFIPAVFRLKDRADQQKYGDIIFDFSYFKGPEL---ESKLDAKPELQDLDE------------FRENNIEIVTRFYLAFQSVHKYIVDLNRYLDDLNEGVYIQQTLETVLLNEDGK---------------------LLCEALYLYGVMLLVIDQKIEGEVRERMLVSY-----YRYSAARSSADSNMDDICKLLRSTGY--SSQPGAKRPSNYPES---------------YFQRVPIN---ESFISMVIGRLSDDIYNQVSAYPLPEHRSTALANQALYFEPSILHTHQAKMREIVDKYFPDNW------VISIYMGITVNLVDAWEPYKAAKTALNNTLDLSNVREQASRYATVSERVH---QVQQFLKEGYLREEMVLDNIPKLLRDCNVAIRWLMLHTADSACDPNNKRLRQIKDQILTDSRYNPRI--LDTAQFEFILKEMFKQMLSEKQTKWEHYKKEGSERMTELADVFSGVKPLTRVEKNENLQAWFREISKQILSLNYDDSTAAGRKTVQLIQALEEVQEFHQLESNLTRKFLHQMIRTINIK-EEVLITMQIVGDLSFAWQLIDSFTSIMQESIRVNPSMVTKLRATF-LKLASAL--------LLRINQANSPDLLSVSQYYIIPESMFTLLKIIKLQTHDIIEVPTRLDKDKLRDYAQLGPRY---------EVAKLTHAISIFTEGILMMKTTLVGIIKVDPK--QLLEDGIRKELVKRVAFALHRGLIFELMPKLKELGATMDGFHRSFEYIQDYVNIYGLKSRIINYNVEQECNNFLRTKIQDWQSMYQSRLCREILRITDPKMDQLNTWYDMKTHQEVTSSRLFSEIQTTNGLDRLLCFMIVKELQNFLS.. 871
9 -6.140PF14961.6; W5NL29_LEPOC/12-1308; Broad-minded protein  ali follow..  1.................................................LQSLLRHLLESVKERIRGAPSAE----------CAEEILLHLEETDENFFIMYLRHYVENM------------VIEAETECCASGEGQGVGPGQDTLVHAVTRRTRESNILSLKNTMMVAVESLINTFEEDKLRKEETHGKSQHEQLSSHYTDNCSDSDCSF------NQSYAFIKQEQLAIAEKIDSSQPKEVRWEALQTLCCAPPSDVLSCESWTGLRRNLSAALGDPDPAFSDKVLK------------FYAKTFSSSPLNITREIYTSLASQKTSFSTAAGLDISNQDVARLLKKMRL---------LNEFQKEVTSFWIRNPEKEEIIESTLSLLSLNLDQSLKTTSADKVLEPIYFLSMLDIKANWGYYSRTVVLRLLENKYKSLIVAS------------------------------LQQCINYYESCESSCDKTSNIAHVRQQQQTGTTQRMFYTARQLEYTYFVHSVC-----LLGRLLMYTHGRKLFPIKLKRRKDPVTLTDLIVILIRIMYRHPIPYYSEIPHVVVDSLSPACLVMDVLRTLCDRKECAVECAIAVIELLLSPIIALLKGKQVNLTSPETTLT---ADILARIATTERGLSLFLYDGNFIYTEGEGISAAHVIVQFTKKLLADKISVLSEAGPLTSLKGAFIFVCRQMYNTCEGLQVLKPYGLHDCIAEAWKQTVSLSERVPTPVPGDCSSSATQDSQ------NNMVWEETLLDNLLNFAATPKG-LLLLQQTGAINECVTYMFSRFTKKLQV-------GVMVTQVAATAPGVAAIWSSG--FVQAIVLELWSVLECGRDEVRMIHPKSTPMDPIDRSC-------QKSFLALVNLLSSYSAVY--ELLVKQELPNKPEYPLREMPTSIIDLIDRLII---INSEAKIHSLFNFEQSH--TFGLRILLDSLLLLESQYRISEILLQSQKDNVSESSGSEGQFIIDGLSIRNHILVRINLIGGPSERFLPPRVLQKGPDPYPWPMFSTYPLPNCYLHDVPKIVPCKQETEISKFLAFSKNPEKQANKQFCKAMATKPDIIKGNVLADLLEKTTIHLSSSPSECFFLSQDYKALDSSVKNQSTLEQLGIKMSIRYGMYLKLIKEDVEQELMKHCQTFLSQQQIKVKSPLCILIKLITHKSSYPGHDWFASSVFLIMSGDKERALKFL----LPFSNLLASAFLWLPRLHASVHHPVDIAESGIHPIYSCTAHYVEMLLKTEVPLVFSAFRMSGFTPSQICLQWLGQCFWNCTCIVMGPDYQTYIEEILQHTQVQDLQVFLKEEPIFSISNYLEYMESLEQKYRTMVLTDM............................................................................................................................................................................................................ 1292
10 -6.090PF15962.5; A9MQT6_SALAR/12-1138; Domain of unknown function (DUF4765 topsan)  ali follow..  10  4..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................QKLNTKGIKTWDTIQYLSALDRAHKDTVFHEQISNLPEEYIHLDEMARD-LNIYEFFFESTAE----------ICEDIKSTLDFYYL--KSPTFRRLV---------NYRVNYSIGNDIDTSKCEVIVSP-----------------------------------------------NYSYQNTEGSSVYLSLPFDKKGFPI---NPESNDCDNNISSEKVLLDLFLKHILYDDLKVDHEVTNLYSNVIYKEIDSTAM--------AHASLCFSQAAVSDKHEL---FNIDSVTVQPKSTEQVIFAGE-EIQKQILFFFERENNFQPATAHKMERNIKNIAVTGLLLSSRLTIADGYG----RKNDNSENKNNFSSDKEPLRYARALPEDHPAPNMEPHGKMIDGIVEHSSFAAGISLFETL--KKIGDEQLMNDYKRGYHELLVFSQTGQWTH-------------------GGRRLTAEYMFNGLIIHLNE--EILINDGGKVSFEHFVREHIEHQYKIYELIARMLVHPIYIRSRIFATRRIASALANESHYTK-VLNQKFPEISSSNFDTFYGKEAIFTALKIVNYYREEKGMSKKMKDLFKRVQLVIRHLSRNGGDKILLSPDGIKYNFSIMRNIIYWCAKITGPVNDKKINALSRKIVVNNETHVKDHIQDCDVLGLMNINKMLRDTVVGLIHEISDIAQSS---LTAEDQHEKQVQALEAFKSKVSSMDG-------QAFVYGFDKVIQEGLWGLIE-----LSFDIDDTVHHRTVSSLSPASRAGLHFLGTIWNIVMSFVPTSSILNRAIVEKSTDVCGYIQDVIRIGMEAAPVAEAKFT-AKYTGLRFVENKIERGVIRSPIQKGSNYKVIESIENIYQKRNNKILELNPEGNDGLYRATGFNKETHGYYKQS............................. 866

FFAS is supported by the NIH grant R01-GM087218-01
1 4 6 5 5 1   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Lesley SA, Kuhn P, Godzik A., Deacon AM, Mathews I, Kreusch A, Spraggon G, Klock HE, McMullan D, Shin T, Vincent J, Robb A, Brinen LS, Miller MD, McPhillips TM, Miller MA, Scheibe D, Canaves JM, Guda C, Jaroszewski L, Selby TL, Elsliger MA, Wooley J, Taylor SS, Hodgson KO, Wilson IA, Schultz PG, Stevens RC. Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline. Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11664-9. Epub 2002 Aug 22.